The Comparative Safety and Effectiveness of dabigatran, versus rivaroxaban, and apixaban Utilized in the Department of Defense (DoD) Non-Valvular Atrial Fibrillation Patient Population-A Retrospective Database Analysis

02/12/2016
02/04/2024
EU PAS number:
EUPAS16528
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information